Home / Knowledge Centre /
Case study

Weighing the options in addressing a supply issue

Mid-trial decisions to address unexpected issues—such as a product shortage—deserve to be made with all the facts. Often, those facts are hard to come by and require visibility to the entire supply chain. That was the case for one sponsor conducting a complex Phase III trial across a number of countries. Almac Clinical Technologies and Almac Clinical Services business units teamed up to provide a complete risk assessment and cost analysis of various solutions, making the most cost-effective choice obvious.

View Resource

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies